TrialOsteoarthritis and cartilage open2021

Safety and pharmacokinetics of EP-104IAR (sustained-release fluticasone propionate) in knee osteoarthritis: A randomized, double-blind, placebo-controlled phase 1 trial.

Amanda Malone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.